M. Griese Et Al. , "Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial.," Trials , vol.21, pp.307, 2020
Griese, M. Et Al. 2020. Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial.. Trials , vol.21 , 307.
Griese, M., Köhler, M., Witt, S., Sebah, D., Kappler, M., Wetzke, M., ... Schwerk, N.(2020). Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial.. Trials , vol.21, 307.
Griese, M Et Al. "Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial.," Trials , vol.21, 307, 2020
Griese, M Et Al. "Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial.." Trials , vol.21, pp.307, 2020
Griese, M. Et Al. (2020) . "Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial.." Trials , vol.21, p.307.
@article{article, author={M Griese Et Al. }, title={Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial.}, journal={Trials}, year=2020, pages={307} }